Healthcare has become one of India’s largest sectors both in terms of revenue and employment. The Indian healthcare sector is growing at a brisk pace due to its strengthening coverage, services and increasing expenditure by public as well private players. The healthcare market can increase three fold to Rs 8.6 trillion by 2022. India is experiencing 22-25 % growth in medical tourism and the industry is expected to reach US$ 9 billion by 2020. There is a significant scope for enhancing healthcare services considering that healthcare spending as a percentage of Gross Domestic Product (GDP) is rising. The government’s expenditure on the health sector has grown to 1.4 % in FY18E from 1.2 % in FY14. The Government of India is planning to increase public healthcare spending to 2.5 % of the country’s GDP by 2025.
Alniche Life Sciences is a specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals products enabling people to live life with greatest potential to see more clearly, move more freely and express themselves more fully. Alniche Life Sciences serves patients and the medical fraternity by offering specialized, high-quality, effective, affordable medicines and wellness products from all around the world. In a rather short period of about a decade, Alniche has carved a firm position for itself in the Indian Pharma market through a focussed approach for key brands and deep engagement with doctors. Its strong portfolio, with products both domestic & licensed from global partners, fulfils the unmet needs of patients in the areas of nephrology, critical care, gastroenterology, dermatology, and advanced wound care. Further the firm also lay emphasise on Renal Care, Critical care, Skinceuticals, Gastroenterology, Advanced Wound Care and Neurology. “Our focus promotes deep engagement with medical specialists and we make it our business to listen to them closely, together we advance in patient care. We combine this strategic focus with a diversified approach that enables us to follow our new specialty areas where unmet needs are significant,” says Girish Arora, Founder, Alniche Life Science.
Bringing Deep and Varied know-how of Wellness
Girish Arora, the founder & managing director of the company, reflecting on the journey of Alniche says, “It all started ten years ago, when after 25 years of experience of heading niche therapy areas in India in various renowned companies, I felt the void for a Nephrology focussed organization covering all Nephrologists across India. Till then most of the organizations had Nephrology as a division with divided focus on this therapy segment. I was convinced that the specialists and patients in
this segment needed greater attention and this conviction was the driving force behind inception of Alniche.”
From a humble beginning of field strength of 50, the company has now expanded to more than 700 and carefully diversified from Nephrology to synergistic segments of Critical care, Gastroenterology, Skinceuticals and now Advanced Woundcare and now Neurology. What started as a modest business venture, Alniche has emerged as a fierce competitor in Nephrology and Critical Care segment and continuing the success story in newly expanded therapy segments. The company is ranked among the top three in Nephrology and top ten in Critical care, pioneering in bringing novel molecules / formulations in Renal Care & Critical care. With more than 1500 distribution points, Alniche covers 30,000 hospitals both in Private /Corporate and Institutional sector. The most appreciable part of Alniche success is the respect that they enjoy from their key customers i.e. doctors, without their continuous support, Alniche would have not attained its growth path. Innovative formulations is one of the major success factor, as Alniche is pioneer in launching Ketoalfa sachet- aimed at improving patient compliance, Auxisoda and Auxisoda DS – enteric coated tablets and Fosfomycin injection. For chronic kidney disease, Alniche has introduced medicines for all the five stages, from pre-dialysis to post transplant stage.
In the Quest of Serving the Clients Better
Quality is the paramount importance for Alniche, hence all the manufacturers are certified with ISO, WHOGMP, and c-GMP certifications. Each product undergoes stringent testing during the manufacturing process, leaving no room for quality grievance. Alniche has its own Medical and Pharmacovigilance department that is engaged in PMS and coordination with manufacturers to ensure quality compliance. For a Life Sciences organization, R&D is a fundamental aspect. Alniche has a dedicated R&D unit backed by experts. The firm annually spends 10 percent of its profits on formulation development. Their key objective is to develop effective formulations for patients, thus contributing towards creation of a healthier India and a healthier world.
Like every new venture, there was a fair share of ups and downs along the way and quite many learning experiences; success was ensured on the back of strong fundamentals, clear vision, patient-centric approach, hand-picked portfolio, and above all a dedicated team. A young team of board of Directors (Ritu Hasija, Sumit Arora, Mehek Arora and Karan Arora) has been the pillar of strength who has been successfully chairing their independent responsibilities for collective achievement of organizational goal. The board is well supported by a strong and proficient senior leadership team of Jayan C.P., Mumtaz Siddique, Praveen Gautam, Pravin Naik, and Bishwa Sahoo. They have remained with the organization in all thick and thin, their loyalty and dedication being the driving force for Alniche’s sales and marketing teams. Implementing Right marketing strategy for Right set of portfolios with Right target audience is the focus for Alniche. A well-designed scientific marketing strategy to repetitively engage with the doctors keeps the company ahead of competitors. This involves various programmes like organizing CMEs, Symposia, Web hosting, Tele-consultations, Disease info & management, Advocacy development, News rooms, Latest in Therapeutic regimen- Book Release, Practice support & decision enhancement tools & few others. Each therapy is promoted by different team thus bringing required Positioning Focus with minimal overlap.
Alniche is committed to making available innovative pharmaceutical products in the Indian market in their pursuit to support medical fraternity in making patients’ lives healthier. They strive to cover entire spectrum of therapy from preventive, curative & maintenance aspects. Additionally, the firm is ready to mark its presence in the complementary market of medical devices and consumables in the selected therapy areas that align well with their pharma range and one such initiative of the firm is an entry into the advanced wound care segment.
Alniche continuously looks for opportunities to partner with global pharma companies as they firmly believe that strategic focus and a differentiated approach empower the organization. To strengthen new speciality divisions for addressing the therapy gaps, in-licensing of novel products in future growth areas is a critical piece of the overall strategy of the company. With this philosophy to the portfolio enrichment, Alniche has partnered with global pharma organizations to bring novel global brands in India from various companies including J W Life Sciences (Korea), Adhezion Biomedical Inc. (USA), FzioMed (USA), Advancis Medical (UK), PT Dermozone Pratama (Indonesia), Biovite (Australia), and Mastix (USA). In addition, the firm is also collaborating with various global companies that focus on therapy differentiation and ground breaking product concepts.
Recently, Alniche has formed an R&D alliance with Delhi Pharmaceutical Sciences & Research University (DPSRU) – India’s first Pharmacy University. This affiliation of industry and academia promises to augment further development of new products enabling innovations to meet the medical needs of Indian population. Additionally, as a part of their professional responsibility, Alniche has instituted awards to encourage the young researchers for the new research and innovative products and ideas. Alniche’s efforts have been recognised through various awards it has been receiving, including the Fastest growing brands & Leadership Award by Asia Once, Healthcare Elite Award by Business APAC and Businessman of the Year by Business Sphere.
The firm with a positive outlook aspires to build strong portfolio by in-licensing global brands and novel domestic products in the years to come. The company also aims to Strengthen speciality focus in marketing activities and to Improve operational efficiencies to ensure better ROI. As Alniche takes new strides into expanded presence in the Indian market, they continue to live the company philosophy of “Inspired By Value, Driven By Vision” and spreading Smiles and Wellness!
